We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ENDV market cap is 838.32k. The company's latest EPS is USD -0.0580 and P/E is 0.00.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 83k | 310k | 166k | 73k | 135k |
| Operating Income | -4.16M | -3.81M | -2.91M | -2.23M | -3.27M |
| Net Income | -6.44M | -17.32M | -396k | -3.11M | -18.48M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.24M | 3.28M | 2.61M | 2.01M | 1.28M |
| Total Liabilities | 15.63M | 21.97M | 16.98M | 17.78M | 33.46M |
| Total Equity | -11.39M | -20.5M | -14.37M | -15.77M | -32.18M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.88M | -2.54M | -742k | -987k | -679k |
| Investing | -9k | -3k | N/A | N/A | N/A |
| Financing | 3.18M | 2.18M | 736k | 1.06M | 593k |
| Market Cap | 838.32k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 318.75M |
| Average Volume (1 week) | 149.79k |
| Average Volume (1 Month) | 534.38k |
| 52 Week Change | -80.52% |
| 52 Week High | 0.02 |
| 52 Week Low | 0.001 |
| Spread (Intraday) | 0 (7.41%) |
| Company Name | Endonovo Therapeutics Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.endonovo.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
